Viewing StudyNCT01015911



Ignite Creation Date: 2024-05-05 @ 10:03 PM
Last Modification Date: 2024-10-26 @ 10:13 AM
Study NCT ID: NCT01015911
Status: COMPLETED
Last Update Posted: 2014-12-18
First Post: 2009-11-13

Brief Title: A Phase 1 Dose-escalation Trial of SGN-75 in CD70-positive Non-Hodgkin Lymphoma or Renal Cell Carcinoma
Sponsor: Seagen Inc
Organization: Seagen Inc

Key Dates - Follows AllAPIJSON File Order

Start Date: 2009-11
Start Date Type: None
Primary Completion Date: 2011-11
Primary Completion Date Type: ACTUAL
Completion Date: 2012-03
Completion Date Type: ACTUAL
First Submit Date: 2009-11-13
First Submit QC Date: November 16 2009
Study First Post Date: 2009-11-18
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-12-17
Last Update Post Date: 2014-12-18
Last Update Post Date Type: ESTIMATED